This clinical trial studies the use of reduced intensity chemotherapy and radiation therapy before donor stem cell transplant in treating patients with hematologic malignancies.
SparkCures ID | 773 |
---|---|
Trial Phase | Phase 2 |
Enrollment | 35 Patients |
Treatments |
|
Tags | |
Trial Sponsors |
|
NCT Identifier |
|
The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.
The following criteria is provided for health care professionals.
Inclusion Criteria:
Patients treated on this study will have:
Exclusion Criteria:
Please visit the ClinicalTrials.gov page for historical site information.
View Centers